Lauren Biscaldi, MS, Managing Editor

Without financial incentives, some senators expressed concerns that pharmaceutical research and development would stall.

Investigators used electronic health record data to compare outcomes of semaglutide vs other antidiabetic medications.

Senators sought to uncover why prices of Novo Nordisk’s GLP-1 receptor agonist semaglutide are significantly higher in the US compared with countries in Europe.

In the US, Ozempic costs more than 9 times what it does in Germany, while Wegovy is more than 4.5 times more expensive than in Denmark.

Eroxon topical gel addresses a significant unmet need for men experiencing erectile dysfunction.

The vaccine will be made available via third-party online pharmacies.

This approval offers an additional treatment option for a disease that can commonly return.

The “cuddle hormone” plays a powerful role in human behavior and may be an additional option to treat pain and manage opioid addiction.

Data from the SELECT clinical trial were analyzed to evaluate the role of semaglutide therapy on all-cause, cardiovascular, and non-cardiovascular mortality during the COVID-19 pandemic.

The #MyCRChistory campaign encourages the public to share their family history of colorectal cancer.

Bezisterim acts on inflammatory signaling pathways and may be a viable treatment option for post–COVID-19 condition, or long COVID.

The vaccine, VAX-31, targets 20 serotypes in common with PCV20, as well as 11 additional serotypes.

Additional data will be presented at a scientific meeting later this year.

Vials of tirzepatide 2.5 mg and 5 mg will be available at a 50% discount compared with the list price of other incretin-based obesity medications.

The device was previously cleared for use in children and adults with type 1 diabetes.

Novavax is still awaiting FDA authorization for their protein-based COVID-19 vaccine.

Addressing the external factors that can have an impact on patient health can make clinical interventions more effective when administered.

The tools that can be used to reduce health disparities exist, but they must be widely disseminated to populations across the US.

Pharmacists can fill a role for patients, but without technology supporting workflows and reimbursement efforts, challenges will remain.

Through Surescripts, pharmacists can cut down on back-and-forth with prescribers’ offices, saving valuable time for patient care.

Pharmacists must be able to view clinical information about patients in order to provide the best clinical care.

However, reimbursement for these services for pharmacists remains a crucial issue.

The National Association of Chain Drug Stores is active at both the federal and state levels in advocating for PBM reform.

Inviting members of Congress into the pharmacy helps legislators experience first hand the value that pharmacists bring to their communities.

Bipartisan support—in a polarized Congress—underscores the importance of pharmacy benefit manager reform.

A collaboration with Blue Cross and Blue Shield of North Carolina focused on commercial populations has improved care and lowered costs in the state.

Both the restructuring of direct and indirect remuneration fees and health care cyber attacks made an impact on the industry in the first half of 2024.

Perhaps unsurprisingly, GLP-1 therapies are expected to continue making headlines within the industry.

To scale up diabetes intervention programs, sustainable workflows, trainings, and payment models are key.

Pharmacists need support—through partnerships and reimbursement—to provide more diverse services to patients.